- Home
- CCRN vs NUVB Comparison
CCRN vs NUVB Comparison
Compare CCRN & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- NUVB
- Stock Information
- Founded
- CCRN 1986
- NUVB 2018
- Country
- CCRN United States
- NUVB United States
- Employees
- CCRN N/A
- NUVB N/A
- Industry
- CCRN Professional Services
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- CCRN Consumer Discretionary
- NUVB Health Care
- Exchange
- CCRN Nasdaq
- NUVB Nasdaq
- Market Cap
- CCRN 586.8M
- NUVB 679.9M
- IPO Year
- CCRN N/A
- NUVB N/A
- Fundamental
- Price
- CCRN $15.93
- NUVB $2.01
- Analyst Decision
- CCRN Buy
- NUVB Strong Buy
- Analyst Count
- CCRN 4
- NUVB 6
- Target Price
- CCRN $18.31
- NUVB $7.67
- AVG Volume (30 Days)
- CCRN 618.5K
- NUVB 2.2M
- Earning Date
- CCRN 03-05-2025
- NUVB 03-06-2025
- Dividend Yield
- CCRN N/A
- NUVB N/A
- EPS Growth
- CCRN N/A
- NUVB N/A
- EPS
- CCRN N/A
- NUVB N/A
- Revenue
- CCRN $1,344,004,000.00
- NUVB $7,873,000.00
- Revenue This Year
- CCRN N/A
- NUVB N/A
- Revenue Next Year
- CCRN $3.21
- NUVB $426.48
- P/E Ratio
- CCRN N/A
- NUVB N/A
- Revenue Growth
- CCRN N/A
- NUVB N/A
- 52 Week Low
- CCRN $9.58
- NUVB $1.67
- 52 Week High
- CCRN $19.25
- NUVB $4.16
- Technical
- Relative Strength Index (RSI)
- CCRN 17.08
- NUVB 40.23
- Support Level
- CCRN $15.56
- NUVB $1.71
- Resistance Level
- CCRN $17.30
- NUVB $2.19
- Average True Range (ATR)
- CCRN 0.25
- NUVB 0.15
- MACD
- CCRN -0.21
- NUVB -0.01
- Stochastic Oscillator
- CCRN 14.29
- NUVB 45.52
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).